Article
State-of-the-Art Strategies for Targeting RET -Dependent Cancers
21 Feb 2020
Abstract excerpt
Activating receptor tyrosine kinase RET (rarranged during transfection) gene alterations have been identified as oncogenic in multiple malignancies. RET gene rearrangements retaining the kinase domain are oncogenic drivers in papillary thyroid cancer, non-small-cell lung cancer, and multiple other cancers. Activating RET mutations are associated with different phenotypes of multiple endocrine neoplasia type 2 as...
Topics
Join the communities discussing this publication.